A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
PLATO
A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]
2 other identifiers
interventional
18,624
43 countries
663
Brief Summary
Ticagrelor is a new, reversible binding, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. Ticagrelor is being developed as a treatment for patients with acute coronary syndrome (ACS). ACS is a term that is used to describe both heart attacks in progress or the imminent threat of a heart attack. ACS is usually caused by the formation of a blood clot in an artery that partially or totally blocks the blood supply to a portion of the heart muscle. Ticagrelor will be compared with clopidogrel to determine which drug, when either is used in conjunction with aspirin, is better at reducing deaths from vascular causes, future heart attacks and/or strokes in patients with ACS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Oct 2006
663 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 23, 2006
CompletedFirst Posted
Study publicly available on registry
October 25, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedResults Posted
Study results publicly available
March 13, 2012
CompletedMarch 13, 2012
February 1, 2012
2.4 years
October 23, 2006
January 31, 2011
February 10, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke
Participants with death from vascular causes, MI, or stroke. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. Intention To Treat (ITT) analysis of whole population. Events were adjudicated by an endpoint committee.
Randomization up to 12 months
Participants With Any Major Bleeding Event
Participants with major (fatal/life-threatening or other) bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. Events were adjudicated by an endpoint committee.
First dosing up to 12 months
Secondary Outcomes (14)
Participants With Any Event From the Composite of Death From Vascular Causes, MI, and Stroke for the Subgroup of Patients With Intent for Invasive Management at Randomization
Randomization up to 12 months
Participants With Any Event From the Composite of All-cause Mortality, MI, and Stroke
Randomization up to 12 months
Participants With Any Event From the Composite of Death From Vascular Causes, MI (Including Silent), Stroke, Recurrent Ischemia, Transient Ischemic Attack (TIA) and Other Arterial Thrombotic Events.
Randomization up to 12 months
Participants With MI Event
Randomization up to 12 months
Participants With Death From Vascular Causes
Randomization up to 12 months
- +9 more secondary outcomes
Study Arms (2)
Clopidogrel
ACTIVE COMPARATOROral treatment
Ticagrelor
EXPERIMENTALOral treatment
Interventions
Eligibility Criteria
You may qualify if:
- Male or female 18 years or older who has been hospitalised for chest pain and potential ACS
- Females of child-bearing potential must have a negative pregnancy test at enrollment and be willing to use 2 methods of reliable contraception
You may not qualify if:
- Persons with moderate or severe liver disease
- Persons who have already been treated with an invasive (angioplasty) procedure for the current episode of ACS
- Persons who are being treated with blood clotting agents that cannot be stopped
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (672)
Research Site
Birmingham, Alabama, United States
Research Site
Huntsville, Alabama, United States
Research Site
Mobile, Alabama, United States
Research Site
Tucson, Arizona, United States
Research Site
Bakersfield, California, United States
Research Site
Beverly Hills, California, United States
Research Site
Burbank, California, United States
Research Site
Healdsburg, California, United States
Research Site
Los Angeles, California, United States
Research Site
Roseville, California, United States
Research Site
Sacramento, California, United States
Research Site
San Diego, California, United States
Research Site
Torrance, California, United States
Research Site
Fort Collins, Colorado, United States
Research Site
Danbury, Connecticut, United States
Research Site
Hartford, Connecticut, United States
Research Site
Newark, Delaware, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Atlantis, Florida, United States
Research Site
Daytona Beach, Florida, United States
Research Site
Fort Lauderdale, Florida, United States
Research Site
Hollywood, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Jupiter, Florida, United States
Research Site
Melbourne, Florida, United States
Research Site
Miami Beach, Florida, United States
Research Site
Ocala, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Ormond Beach, Florida, United States
Research Site
Pensacola, Florida, United States
Research Site
Sarasota, Florida, United States
Research Site
St. Petersburg, Florida, United States
Research Site
Chicago, Illinois, United States
Research Site
Park Ridge, Illinois, United States
Research Site
Rock Island, Illinois, United States
Research Site
Rockford, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Muncie, Indiana, United States
Research Site
Valparaiso, Indiana, United States
Research Site
Iowa City, Iowa, United States
Research Site
West Des Moines, Iowa, United States
Research Site
Kansas City, Kansas, United States
Research Site
Olathe, Kansas, United States
Research Site
Ashland, Kentucky, United States
Research Site
Louisville, Kentucky, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Auburn, Maine, United States
Research Site
Bangor, Maine, United States
Research Site
Baltimore, Maryland, United States
Research Site
Bethesda, Maryland, United States
Research Site
Salisbury, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
Springfield, Massachusetts, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Kalamazoo, Michigan, United States
Research Site
Lansing, Michigan, United States
Research Site
Laper, Michigan, United States
Research Site
Pontiac, Michigan, United States
Research Site
Royal Oak, Michigan, United States
Research Site
Saginaw, Michigan, United States
Research Site
Troy, Michigan, United States
Research Site
Ypsilanti, Michigan, United States
Research Site
Duluth, Minnesota, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Saint Paul, Minnesota, United States
Research Site
Tupelo, Mississippi, United States
Research Site
Columbia, Missouri, United States
Research Site
Joplin, Missouri, United States
Research Site
Kansas City, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Omaha, Nebraska, United States
Research Site
Papillion, Nebraska, United States
Research Site
Newark, New Jersey, United States
Research Site
Oakland, New Jersey, United States
Research Site
Paterson, New Jersey, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Brooklyn, New York, United States
Research Site
Buffalo, New York, United States
Research Site
Johnson City, New York, United States
Research Site
Kingston, New York, United States
Research Site
New Hartford, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Syracuse, New York, United States
Research Site
Williamsville, New York, United States
Research Site
Chapel Hill, North Carolina, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Greensboro, North Carolina, United States
Research Site
High Point, North Carolina, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Cleveland, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Kettering, Ohio, United States
Research Site
Zanesville, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Tulsa, Oklahoma, United States
Research Site
Bend, Oregon, United States
Research Site
Camp Hill, Pennsylvania, United States
Research Site
Danville, Pennsylvania, United States
Research Site
Doylestown, Pennsylvania, United States
Research Site
Harrisburg, Pennsylvania, United States
Research Site
Lancaster, Pennsylvania, United States
Research Site
Langhorne, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Sayre, Pennsylvania, United States
Research Site
Sellersville, Pennsylvania, United States
Research Site
Wormleysburg, Pennsylvania, United States
Research Site
York, Pennsylvania, United States
Research Site
Providence, Rhode Island, United States
Research Site
Wakefield, Rhode Island, United States
Research Site
Anderson, South Carolina, United States
Research Site
Charleston, South Carolina, United States
Research Site
Columbia, South Carolina, United States
Research Site
Greenville, South Carolina, United States
Research Site
Rapid City, South Dakota, United States
Research Site
Jackson, Tennessee, United States
Research Site
Knoxville, Tennessee, United States
Research Site
Memphis, Tennessee, United States
Research Site
Amarillo, Texas, United States
Research Site
Austin, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Lubbock, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
San Marcos, Texas, United States
Research Site
Tyler, Texas, United States
Research Site
Victoria, Texas, United States
Research Site
Burlington, Vermont, United States
Research Site
Falls Church, Virginia, United States
Research Site
Fredericksburg, Virginia, United States
Research Site
Norfolk, Virginia, United States
Research Site
Winchester, Virginia, United States
Research Site
Everett, Washington, United States
Research Site
Tacoma, Washington, United States
Research Site
Morgantown, West Virginia, United States
Research Site
Green Bay, Wisconsin, United States
Research Site
Adrogué, Buenos Aires, Argentina
Research Site
Buenos Aires, Buenos Aires, Argentina
Research Site
Capital Federal, Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Bs. As., Buenos Aires, Argentina
Research Site
Quilmes, Buenos Aires, Argentina
Research Site
Corrientes, Corrientes Province, Argentina
Research Site
Córdoba, Córdoba Province, Argentina
Research Site
Morón, Pcia. de Buenos Aires, Argentina
Research Site
Salta, Salta Province, Argentina
Research Site
Rosario, Santa Fe Province, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina
Research Site
San Miguel de Tucumán, Tucuman - Argentina, Argentina
Research Site
San Miguel de Tucumán, Argentina
Research Site
Bruce, Australian Capital Territory, Australia
Research Site
Chermside, Queensland, Australia
Research Site
Herston, Queensland, Australia
Research Site
Woolloongabba, Queensland, Australia
Research Site
Bedford Park, South Australia, Australia
Research Site
Dandenong, Victoria, Australia
Research Site
Geelong, Victoria, Australia
Research Site
Melbourne, Victoria, Australia
Research Site
Perth, Western Australia, Australia
Research Site
Feldkirch, Austria
Research Site
Freistadt, Austria
Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Linz, Austria
Research Site
Mödling, Austria
Research Site
Vienna, Austria
Research Site
Villach, Austria
Research Site
Aalst, Belgium, Belgium
Research Site
Bouge, Belgium, Belgium
Research Site
Brasschaat, Belgium, Belgium
Research Site
Brussels (anderlecht), Belgium, Belgium
Research Site
Charleroi, Belgium, Belgium
Research Site
Edegem, Belgium, Belgium
Research Site
Genk, Belgium, Belgium
Research Site
Hasselt, Belgium, Belgium
Research Site
Huy, Belgium, Belgium
Research Site
Liège, Belgium, Belgium
Research Site
Mechelen, Belgium, Belgium
Research Site
Mol, Belgium, Belgium
Research Site
Wilrijk, Belgium, Belgium
Research Site
Maceió, Alagoas, Brazil
Research Site
Salvador, Estado de Bahia, Brazil
Research Site
Brasília, Federal District, Brazil
Research Site
Goiânia, Goiás, Brazil
Research Site
Campo Grande, Mato Grosso do Sul, Brazil
Research Site
Belo Horizonte, Minas Gerais, Brazil
Research Site
Uberlândia, Minas Gerais, Brazil
Research Site
Curitiba, Paraná, Brazil
Research Site
Maringá, Paraná, Brazil
Research Site
Recife, Pernambuco, Brazil
Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
Research Site
Natal, Rio Grande do Norte, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
São José, Santa Catarina, Brazil
Research Site
Aracaju, Sergipe, Brazil
Research Site
S.j.rio Preto, São Paulo, Brazil
Research Site
São Paulo, São Paulo, Brazil
Research Site
Campinas, Brazil
Research Site
Burgas, Bulgaria
Research Site
Dimitrovgrad, Bulgaria
Research Site
Gabrovo, Bulgaria
Research Site
Haskovo, Bulgaria
Research Site
Kazanlak, Bulgaria
Research Site
Pleven, Bulgaria
Research Site
Plovdiv, Bulgaria
Research Site
Rousse, Bulgaria
Research Site
Smolyan, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Varna, Bulgaria
Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Campbell River, British Columbia, Canada
Research Site
Kelowna, British Columbia, Canada
Research Site
New Westminster, British Columbia, Canada
Research Site
Penticton, British Columbia, Canada
Research Site
Surrey, British Columbia, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Victoria, British Columbia, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Saint John, New Brunswick, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Brockville, Ontario, Canada
Research Site
Cambridge, Ontario, Canada
Research Site
Cornwall, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Newmarket, Ontario, Canada
Research Site
Oshawa, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Scarborough Village, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Laval, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Saint-Georges, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Research Site
Thetford-Mines, Quebec, Canada
Research Site
Regina, Saskatchewan, Canada
Research Site
Beijing, China, China
Research Site
Shanghai, Pudong, China, China
Research Site
Guangzhou, Guangdong, China
Research Site
Shenyang, Liaoning, China
Research Site
Chengdu, Sichuan, China
Research Site
Hangzhou, China
Research Site
Brno, CZ, Czechia
Research Site
Hradec Králové, Czechia
Research Site
Jihlava, Czechia
Research Site
Kladno, Czechia
Research Site
Liberec, Czechia
Research Site
Olomouc, Czechia
Research Site
Ostrava-poruba, Czechia
Research Site
Pardubice, Czechia
Research Site
Prague, Czechia
Research Site
Slaný, Czechia
Research Site
Teplice, Czechia
Research Site
Ústí nad Labem, Czechia
Research Site
Ústí nad Orlicí, Czechia
Research Site
Zlín, Czechia
Research Site
Znojmo, Czechia
Research Site
Copenhagen, Denmark
Research Site
Esbjerg, Denmark
Research Site
Fredericia, Denmark
Research Site
Frederiksberg, Denmark
Research Site
Frederikssund, Denmark
Research Site
Glostrup Municipality, Denmark
Research Site
Hellerup, Denmark
Research Site
Herlev, Denmark
Research Site
Herning, Denmark
Research Site
Hillerød, Denmark
Research Site
Hjørring, Denmark
Research Site
Holbæk, Denmark
Research Site
Horsens, Denmark
Research Site
Hvidovre, Denmark
Research Site
Kolding, Denmark
Research Site
Køge, Denmark
Research Site
Næstved, Denmark
Research Site
Odense C, Denmark
Research Site
Roskilde, Denmark
Research Site
Silkeborg, Denmark
Research Site
Slagelse, Denmark
Research Site
Viborg, Denmark
Research Site
Kokkola, Finland, Finland
Research Site
Rovaniemi, Finland, Finland
Research Site
Turku, Finland, Finland
Research Site
Hus (helsinki), Finland
Research Site
Jyväskylä, Finland
Research Site
Kuopio, Finland
Research Site
Lahti, Finland
Research Site
Lappeenranta, Finland
Research Site
Pori, Finland
Research Site
Abbeville, France
Research Site
Allauch, France
Research Site
Arras, France
Research Site
Avignon, France
Research Site
Bayonne, France
Research Site
Besançon, France
Research Site
Brest, France
Research Site
Caen, France
Research Site
Cholet, France
Research Site
Créteil, France
Research Site
Croix, France
Research Site
Dijon, France
Research Site
Douai, France
Research Site
Falaise, France
Research Site
Fréjus, France
Research Site
La Rochelle, France
Research Site
Lagny-sur-Marne, France
Research Site
Lille, France
Research Site
Limoges, France
Research Site
Lomme, France
Research Site
Marseille, France
Research Site
Nîmes, France
Research Site
Orléans, France
Research Site
Paris, France
Research Site
Pau, France
Research Site
Pessac, France
Research Site
Quincy-sous-Sénart, France
Research Site
Rennes, France
Research Site
Rouen, France
Research Site
Senlis, France
Research Site
Strasbourg, France
Research Site
Toulouse, France
Research Site
Tourcoing, France
Research Site
Valenciennes, France
Research Site
Tbilisi, Georgia
Research Site
Aschaffenburg, Germany
Research Site
Bad Mergentheim, Germany
Research Site
Bad Nauheim, Germany
Research Site
Bad Rothenfelde, Germany
Research Site
Berlin, Germany
Research Site
Bochum, Germany
Research Site
Bonn, Germany
Research Site
Cloppenburg, Germany
Research Site
Coburg, Germany
Research Site
Dortmund, Germany
Research Site
Dresden, Germany
Research Site
Duisburg, Germany
Research Site
Erfurt, Germany
Research Site
Essen, Germany
Research Site
Esslingen am Neckar, Germany
Research Site
Frankfurt, Germany
Research Site
Göttingen, Germany
Research Site
Greifswald, Germany
Research Site
Halle, Germany
Research Site
Hamburg, Germany
Research Site
Hanover, Germany
Research Site
Heidelberg, Germany
Research Site
Jena, Germany
Research Site
Kiel, Germany
Research Site
Krefeld, Germany
Research Site
Limburg, Germany
Research Site
Lübeck, Germany
Research Site
Mainz, Germany
Research Site
Merseburg, Germany
Research Site
Mönchengladbach, Germany
Research Site
Muhlheim An Der Ruhr, Germany
Research Site
Münster, Germany
Research Site
Regensburg, Germany
Research Site
Rostock, Germany
Research Site
Ulm, Germany
Research Site
Warendorf, Germany
Research Site
Witten, Germany
Research Site
Wuppertal, Germany
Research Site
Würzburg, Germany
Research Site
Heraklion, Crete, Greece
Research Site
Athens, Greece, Greece
Research Site
Larissa, Greece, Greece
Research Site
Piraeus, Greece, Greece
Research Site
Thessaloniki, Greece, Greece
Research Site
Pátrai, Greece
Research Site
Hong Kong, Hong Kong
Research Site
Budapest, Hungary
Research Site
Cegléd, Hungary
Research Site
Debrecen, Hungary
Research Site
Gyula, Hungary
Research Site
Hodmez-vasarhely, Hungary
Research Site
Kaposvár, Hungary
Research Site
Kecskemét, Hungary
Research Site
Mosonmagyaróvár, Hungary
Research Site
Pécs, Hungary
Research Site
Székesfehérvár, Hungary
Research Site
Zalaegerszeg, Hungary
Research Site
Hyderabad, Andhrapradesh, India
Research Site
Vijayawada, Andhrapradesh, India
Research Site
Ahmedabad, Gujarat, India
Research Site
Gandhinagar, Gujarat, India
Research Site
Vadodara, Gujarat, India
Research Site
Bangalore, Karnataka, India
Research Site
Kochi, Kerala, India
Research Site
Thrissur, Kerala, India
Research Site
Bhopal, Madhya Pradesh, India
Research Site
Mumbai, Maharashtra, India
Research Site
Nagpur, Maharashtra, India
Research Site
New Delhi, National Capital Territory of Delhi, India
Research Site
Patiāla, Punjab, India
Research Site
Bikaner, Rajasthan, India
Research Site
Jaipur, Rajasthan, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Coimabatore, Tamil Nadu, India
Research Site
Kolkata, West Bengal, India
Research Site
Denpasar, Bali, Indonesia
Research Site
Surabaya, East Java, Indonesia
Research Site
Bandung, West Java, Indonesia
Research Site
Jakarta, Indonesia
Research Site
Makassar, Indonesia
Research Site
Semarang, Indonesia
Research Site
Afula, Israel
Research Site
Ashkelon, Israel
Research Site
Beersheba, Israel
Research Site
Hadera, Israel
Research Site
Haifa, Israel
Research Site
Holon, Israel
Research Site
Jerusalem, Israel
Research Site
Poriya M.p. Lower Galilee, Israel
Research Site
Rehovot, Israel
Research Site
Tel Aviv, Israel
Research Site
Ẕerifin, Israel
Research Site
Ancona, AN, Italy
Research Site
Bari, BA, Italy
Research Site
Bergamo, BG, Italy
Research Site
Caserta, CE, Italy
Research Site
Catania, CT, Italy
Research Site
Ferrara, FE, Italy
Research Site
Foggia, FG, Italy
Research Site
San Giovanni Rotondo, FG, Italy
Research Site
Bagno a Ripoli, FI, Italy
Research Site
Florence, FI, Italy
Research Site
Legnano, MI, Italy
Research Site
Milan, MI, Italy
Research Site
Monza, MI, Italy
Research Site
Rozzano, MI, Italy
Research Site
Mantova, MN, Italy
Research Site
Modena, MO, Italy
Research Site
Pescara, PE, Italy
Research Site
Parma, PR, Italy
Research Site
Pavia, PV, Italy
Research Site
Lido di Ostia, Roma, Italy
Research Site
Sassari, SS, Italy
Research Site
Treviso, TV, Italy
Research Site
Varese, VA, Italy
Research Site
Mestre, VE, Italy
Research Site
Verona, VR, Italy
Research Site
Massa Carrara, Italy
Research Site
Napoli, Italy
Research Site
Novara, Italy
Research Site
Roma, Italy
Research Site
Kuala Lumpur, Kuala Lumpur, Malaysia
Research Site
Kuching, Sarawak, Malaysia
Research Site
George Town, Malaysia
Research Site
Durango, Durango, Mexico
Research Site
Guadalajara, Jalisco, Mexico
Research Site
Zapopan, Jalisco, Mexico
Research Site
Mexico City, Mexico City, Mexico
Research Site
Monterrey, Nuevo León, Mexico
Research Site
Puebla City, Puebla, Mexico
Research Site
Alkmaar, Netherlands
Research Site
Almelo, Netherlands
Research Site
Amersfoort, Netherlands
Research Site
Amsterdam, Netherlands
Research Site
Apeldoorn, Netherlands
Research Site
Arnhem, Netherlands
Research Site
Assen, Netherlands
Research Site
Blaricum, Netherlands
Research Site
Breda, Netherlands
Research Site
Capelle aan den IJssel, Netherlands
Research Site
Delft, Netherlands
Research Site
Deventer, Netherlands
Research Site
Dordrecht, Netherlands
Research Site
Drachten, Netherlands
Research Site
Ede, Netherlands
Research Site
Eindhoven, Netherlands
Research Site
Goes, Netherlands
Research Site
Gorinchem, Netherlands
Research Site
Gouda, Netherlands
Research Site
Haarlem, Netherlands
Research Site
Hardenberg, Netherlands
Research Site
Harderwijk, Netherlands
Research Site
Heerlen, Netherlands
Research Site
Helmond, Netherlands
Research Site
Hilversum, Netherlands
Research Site
Leeuwarden, Netherlands
Research Site
Maastricht, Netherlands
Research Site
Nieuwegein, Netherlands
Research Site
Nijmegen, Netherlands
Research Site
Rotterdam, Netherlands
Research Site
Spijkenisse, Netherlands
Research Site
The Hague, Netherlands
Research Site
Tiel, Netherlands
Research Site
Tilburg, Netherlands
Research Site
Veldhoven, Netherlands
Research Site
Vlaardingen, Netherlands
Research Site
Arendal, Norway
Research Site
Bergen, Norway
Research Site
Bodø, Norway
Research Site
Drammen, Norway
Research Site
Flekkefjord, Norway
Research Site
Gjøvik, Norway
Research Site
Hamar, Norway
Research Site
Kongsberg, Norway
Research Site
Kristiansand, Norway
Research Site
Lillehammer, Norway
Research Site
Nordbyhagen, Norway
Research Site
Notodden, Norway
Research Site
Oslo, Norway
Research Site
Rud, Norway
Research Site
Tromsø, Norway
Research Site
Tynset, Norway
Research Site
Pasig, Philippines, Philippines
Research Site
Cebu, Philippines
Research Site
Davao City, Philippines
Research Site
Manila, Philippines
Research Site
Quezon City, Philippines
Research Site
Bialystok, Poland
Research Site
Bielsko-Biala, Poland
Research Site
Bydgoszcz, Poland
Research Site
Bytom, Poland
Research Site
Częstochowa, Poland
Research Site
Elblag, Poland
Research Site
Gda?sk, Poland
Research Site
Gdynia, Poland
Research Site
Grodzisk Mazowiecki, Poland
Research Site
Inowrocław, Poland
Research Site
Katowice, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Olsztyn, Poland
Research Site
Opole, Poland
Research Site
Ostrowiec Świętokrzyski, Poland
Research Site
Oława, Poland
Research Site
Poznan, Poland
Research Site
Płock, Poland
Research Site
Radom, Poland
Research Site
Szczecin, Poland
Research Site
Tarnów, Poland
Research Site
Torun, Poland
Research Site
Warsaw, Poland
Research Site
Wałbrzych, Poland
Research Site
Wejherowo, Poland
Research Site
Wroclaw, Poland
Research Site
Włocławek, Poland
Research Site
Zamość, Poland
Research Site
Amadora, Portugal
Research Site
Aveiro, Portugal
Research Site
Braga, Portugal
Research Site
Coimbra, Portugal
Research Site
Leiria, Portugal
Research Site
Lisbon, Portugal
Research Site
Penafiel, Portugal
Research Site
Santa Maria da Feira, Portugal
Research Site
Santarém, Portugal
Research Site
Setúbal, Portugal
Research Site
Vila Nova de Gaia, Portugal
Research Site
Vila Real, Portugal
Research Site
San Juan, Puerto Rico
Research Site
Piteşti, Argeş, Romania
Research Site
Brasov, Brașov County, Romania
Research Site
Brăila, Brăila County, Romania
Research Site
Cluj-Napoca, Cluj, Romania
Research Site
Iași, Iaşi, Romania
Research Site
Bucharest, Romania
Research Site
Buzău, Romania
Research Site
Craiova, Romania
Research Site
Iași, Romania
Research Site
Suceava, Romania
Research Site
Khanty-Mansiysk, Khanty-mansiysk Autonomous Dis, Russia
Research Site
Barnaul, Russia
Research Site
Irkutsk, Russia
Research Site
Kaliningrad, Russia
Research Site
Kazan', Russia
Research Site
Kemerovo, Russia
Research Site
Krasnodar, Russia
Research Site
Krasnoyarsk, Russia
Research Site
Moscow, Russia
Research Site
Murmansk, Russia
Research Site
Nizhny Novgorod, Russia
Research Site
Novosibirsk, Russia
Research Site
Rostov-on-Don, Russia
Research Site
Saint Petersburg, Russia
Research Site
Samara, Russia
Research Site
Tomsk, Russia
Research Site
Tyumen, Russia
Research Site
Vladivostok, Russia
Research Site
Yekaterinburg, Russia
Research Site
Singapore, Singapore, Singapore
Research Site
Bratislava, Slovakia
Research Site
Košice, Slovakia
Research Site
Liptovský Mikuláš, Slovakia
Research Site
Martin, Slovakia
Research Site
Nitra, Slovakia
Research Site
Nové Zámky, Slovakia
Research Site
Piešťany, Slovakia
Research Site
Ružomberok, Slovakia
Research Site
Trnava, Slovakia
Research Site
Žilina, Slovakia
Research Site
Cape Town, Cape Town, South Africa
Research Site
Somerset West, Cape Town, South Africa
Research Site
Bloemfontein, Free State, South Africa
Research Site
Pretoria, South Africa
Research Site
Seongnam, Gyeonggido, South Korea
Research Site
Daegu, South Korea
Research Site
Gwangju, South Korea
Research Site
Seoul, South Korea
Research Site
Suwon, South Korea
Research Site
Wŏnju, South Korea
Research Site
Málaga, Andalusia, Spain
Research Site
Seville, Andalusia, Spain
Research Site
Palma de Mallorca, Balearic Islands, Spain
Research Site
Barcelona, Catalonia, Spain
Research Site
Lleida, Catalonia, Spain
Research Site
Terrassa, Catalonia, Spain
Research Site
Cáceres, Extremadura, Spain
Research Site
Vigo(pontevedra), Galicia, Spain
Research Site
Madrid, Madrid, Spain
Research Site
Gijón, Principality of Asturias, Spain
Research Site
Valencia, Valencia, Spain
Research Site
Borås, Sweden
Research Site
Eksjö, Sweden
Research Site
Eskilstuna, Sweden
Research Site
Falun, Sweden
Research Site
Halmstad, Sweden
Research Site
Jönköping, Sweden
Research Site
Kalmar, Sweden
Research Site
Karlskrona, Sweden
Research Site
Lidköping, Sweden
Research Site
Linköping, Sweden
Research Site
Ljungby, Sweden
Research Site
Lund, Sweden
Research Site
Östersund, Sweden
Research Site
Skövde, Sweden
Research Site
Stockholm, Sweden
Research Site
Sundsvall, Sweden
Research Site
Uppsala, Sweden
Research Site
Västerås, Sweden
Research Site
Mendrisio, Canton Ticino, Switzerland
Research Site
Bellinzona, Switzerland
Research Site
Bern, Switzerland
Research Site
Geneva, Switzerland
Research Site
Kreuzlingen, Switzerland
Research Site
Lugano, Switzerland
Research Site
Niao-song-shiang, Kaohsiung, Taiwan
Research Site
Kweishan Shiang, Taoyuan Hsien, Taiwan
Research Site
Taipei, Taiwan
Research Site
Bangkok, Bangkok, Thailand
Research Site
Chiang Mai, Thailand, Thailand
Research Site
Khon Kaen, Thailand, Thailand
Research Site
Istanbul, Kartal, Turkey (Türkiye)
Research Site
Ankara, Sihhiye, Turkey (Türkiye)
Research Site
Adana, Turkey (Türkiye)
Research Site
Antalya, Turkey (Türkiye)
Research Site
Mersin, Turkey (Türkiye)
Research Site
Dnipro, Ukraine
Research Site
Donetsk, Ukraine
Research Site
Kharkiv, Ukraine
Research Site
Kiev, Ukraine
Research Site
Makiyivka, Ukraine
Research Site
Airdrie, Lanarkshire, United Kingdom
Research Site
Belfast, Northern Ireland, United Kingdom
Research Site
Basingstoke, United Kingdom
Research Site
Birmingham, United Kingdom
Research Site
Blackpool, United Kingdom
Research Site
Dundee, United Kingdom
Research Site
Edinburgh, United Kingdom
Research Site
Glasgow, United Kingdom
Research Site
Leicester, United Kingdom
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Middlesbrough, United Kingdom
Research Site
Poole, United Kingdom
Research Site
Sheffield, United Kingdom
Research Site
Swansea, United Kingdom
Related Publications (62)
Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D. Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy. Am J Ther. 2023 Sep-Oct 01;30(5):e411-e415. doi: 10.1097/MJT.0000000000001622. Epub 2023 Mar 29.
PMID: 37713684DERIVEDHjort M, Eggers KM, Lakic TG, Lindback J, Budaj A, Cornel JH, Giannitsis E, Katus HA, Siegbahn A, Storey RF, Becker RC, Wallentin L, Lindahl B; PLATO trial investigators*. Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial. J Am Heart Assoc. 2023 Jan 3;12(1):e027466. doi: 10.1161/JAHA.122.027466. Epub 2022 Dec 24.
PMID: 36565198DERIVEDBatra G, Lindback J, Becker RC, Harrington RA, Held C, James SK, Kempf T, Lopes RD, Mahaffey KW, Steg PG, Storey RF, Swahn E, Wollert KC, Siegbahn A, Wallentin L. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 Nov 1;80(18):1735-1747. doi: 10.1016/j.jacc.2022.08.767.
PMID: 36302586DERIVEDNatale P, Palmer SC, Saglimbene VM, Ruospo M, Razavian M, Craig JC, Jardine MJ, Webster AC, Strippoli GF. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.
PMID: 35224730DERIVEDSamman KN, Mehanna P, Takla E, Grenier JC, Chan MY, Lopes RD, Neely ML, Wang TY, Newby LK, Becker RC, Lordkipanidze M, Ruiz M, Hussin JG, Jolicoeur EM. Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel. Cell Rep Med. 2021 Jun 4;2(6):100299. doi: 10.1016/j.xcrm.2021.100299. eCollection 2021 Jun 15.
PMID: 34195679DERIVEDThi Thu Nguyen T, Van Do D, Mellstrom C, Quang Nguyen T, Manh Pham H, Van Hoang S, Cong Luu T, Le Phuong T. Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers' Perspective. Adv Ther. 2021 Jul;38(7):4026-4039. doi: 10.1007/s12325-021-01743-5. Epub 2021 Jun 11.
PMID: 34115329DERIVEDMahmoodi BK, Eriksson N, Vos GJA, Meijer K, Siegbahn A, James S, Wallentin L, Ten Berg JM. Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis. J Am Heart Assoc. 2021 Jun;10(11):e020025. doi: 10.1161/JAHA.120.020025. Epub 2021 May 17.
PMID: 33998271DERIVEDGregersen I, Michelsen AE, Lunde NN, Akerblom A, Lakic TG, Skjelland M, Ryeng Skagen K, Becker RC, Lindback J, Himmelmann A, Solberg R, Johansen HT, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Ueland T, Wallentin L, Halvorsen B. Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Heart Assoc. 2020 Sep;9(17):e016360. doi: 10.1161/JAHA.120.016360. Epub 2020 Aug 15.
PMID: 32809893DERIVEDSumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Himmelmann A, Ajjan RA, Storey RF. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study. Thromb Haemost. 2020 Mar;120(3):412-422. doi: 10.1055/s-0039-1701011. Epub 2020 Jan 23.
PMID: 31975352DERIVEDUeland T, Akerblom A, Ghukasyan T, Michelsen AE, Becker RC, Bertilsson M, Budaj A, Cornel JH, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Wallentin L; PLATO Investigators. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial. Atherosclerosis. 2020 Jan;293:35-41. doi: 10.1016/j.atherosclerosis.2019.11.031. Epub 2019 Nov 29.
PMID: 31835039DERIVEDAndersen T, Ueland T, Ghukasyan Lakic T, Akerblom A, Bertilsson M, Aukrust P, Michelsen AE, James SK, Becker RC, Storey RF, Wallentin L, Siegbahn A, Kontny F. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2402-2410. doi: 10.1161/ATVBAHA.119.312633. Epub 2019 Sep 26.
PMID: 31554419DERIVEDAkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza Brito F, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF, Becker RC, Lopes RD; PLATO Investigators. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2019 Jul;213:57-65. doi: 10.1016/j.ahj.2019.04.006. Epub 2019 Apr 18.
PMID: 31108273DERIVEDFranchi F, James SK, Ghukasyan Lakic T, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Storey RF, Himmelmann A, Wallentin L, Angiolillo DJ; PLATO Investigators. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial. J Am Heart Assoc. 2019 Mar 19;8(6):e011139. doi: 10.1161/JAHA.118.011139.
PMID: 30857464DERIVEDLindholm D, James SK, Gabrysch K, Storey RF, Himmelmann A, Cannon CP, Mahaffey KW, Steg PG, Held C, Siegbahn A, Wallentin L. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. JAMA Cardiol. 2018 Dec 1;3(12):1160-1166. doi: 10.1001/jamacardio.2018.3811.
PMID: 30427997DERIVEDInohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome. Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28.
PMID: 29910052DERIVEDUeland T, Akerblom A, Ghukasyan T, Michelsen AE, Aukrust P, Becker RC, Bertilsson M, Himmelmann A, James SK, Siegbahn A, Storey RF, Kontny F, Wallentin L; PLATO (Platelet Inhibition and Patient Outcomes) Trial Investigators. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Heart Assoc. 2018 Jan 12;7(2):e007009. doi: 10.1161/JAHA.117.007009.
PMID: 29330256DERIVEDBellavia A, Wallentin L, Orsini N, James SK, Cannon CP, Himmelmann A, Sundstrom J, Renlund H, Lytsy P. Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial. Open Heart. 2017 Jun 1;4(2):e000557. doi: 10.1136/openhrt-2016-000557. eCollection 2017.
PMID: 28761675DERIVEDLindholm D, Hagstrom E, James SK, Becker RC, Cannon CP, Himmelmann A, Katus HA, Maurer G, Lopez-Sendon JL, Steg PG, Storey RF, Siegbahn A, Wallentin L. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding. J Am Heart Assoc. 2017 Apr 14;6(4):e005580. doi: 10.1161/JAHA.117.005580.
PMID: 28411246DERIVEDLindholm D, James SK, Bertilsson M, Becker RC, Cannon CP, Giannitsis E, Harrington RA, Himmelmann A, Kontny F, Siegbahn A, Steg PG, Storey RF, Velders MA, Weaver WD, Wallentin L; PLATO Investigators. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome. Clin Chem. 2017 Feb;63(2):573-584. doi: 10.1373/clinchem.2016.261271. Epub 2016 Dec 8.
PMID: 27932413DERIVEDHeld P, Himmelmann A, Ditmarsch M. Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program. Future Cardiol. 2016 Jul;12(4):405-18. doi: 10.2217/fca-2016-0028. Epub 2016 May 10.
PMID: 27160944DERIVEDJohansson A, Eriksson N, Lindholm D, Varenhorst C, James S, Syvanen AC, Axelsson T, Siegbahn A, Barratt BJ, Becker RC, Himmelmann A, Katus HA, Steg PG, Storey RF, Wallentin L; PLATO Investigators. Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome. Hum Mol Genet. 2016 Apr 1;25(7):1447-56. doi: 10.1093/hmg/ddw012. Epub 2016 Jan 21.
PMID: 26908625DERIVEDVelders MA, Abtan J, Angiolillo DJ, Ardissino D, Harrington RA, Hellkamp A, Himmelmann A, Husted S, Katus HA, Meier B, Schulte PJ, Storey RF, Wallentin L, Gabriel Steg P, James SK; PLATO Investigators. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention. Heart. 2016 Apr;102(8):617-25. doi: 10.1136/heartjnl-2015-308963. Epub 2016 Feb 4.
PMID: 26848185DERIVEDBui AH, Cannon CP, Steg PG, Storey RF, Husted S, Guo J, Im K, James SK, Michelson EL, Himmelmann A, Held C, Varenhorst C, Wallentin L, Scirica BM. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e002951. doi: 10.1161/CIRCEP.115.002951.
PMID: 26810596DERIVEDAndell P, James SK, Cannon CP, Cyr DD, Himmelmann A, Husted S, Keltai M, Koul S, Santoso A, Steg PG, Storey RF, Wallentin L, Erlinge D; PLATO Investigators. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Heart Assoc. 2015 Oct 9;4(10):e002490. doi: 10.1161/JAHA.115.002490.
PMID: 26452988DERIVEDHagstrom E, James SK, Bertilsson M, Becker RC, Himmelmann A, Husted S, Katus HA, Steg PG, Storey RF, Siegbahn A, Wallentin L; PLATO Investigators. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. Eur Heart J. 2016 Apr 21;37(16):1325-33. doi: 10.1093/eurheartj/ehv491. Epub 2015 Sep 28.
PMID: 26417057DERIVEDMahaffey KW, Hager R, Wojdyla D, White HD, Armstrong PW, Alexander JH, Tricoci P, Lopes RD, Ohman EM, Roe MT, Harrington RA, Wallentin L. Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. J Am Heart Assoc. 2015 Jun 18;4(6):e001512. doi: 10.1161/JAHA.114.001512.
PMID: 26089177DERIVEDKang HJ, Clare RM, Gao R, Held C, Himmelmann A, James SK, Lim ST, Santoso A, Yu CM, Wallentin L, Becker RC; PLATO Investigators. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2015 Jun;169(6):899-905.e1. doi: 10.1016/j.ahj.2015.03.015. Epub 2015 Mar 31.
PMID: 26027629DERIVEDVelders MA, Wallentin L, Becker RC, van Boven AJ, Himmelmann A, Husted S, Katus HA, Lindholm D, Morais J, Siegbahn A, Storey RF, Wernroth L, James SK; PLATO Investigators. Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial. Am Heart J. 2015 Jun;169(6):879-889.e7. doi: 10.1016/j.ahj.2015.02.019. Epub 2015 Mar 5.
PMID: 26027627DERIVEDVarenhorst C, Eriksson N, Johansson A, Barratt BJ, Hagstrom E, Akerblom A, Syvanen AC, Becker RC, James SK, Katus HA, Husted S, Steg PG, Siegbahn A, Voora D, Teng R, Storey RF, Wallentin L; PLATO Investigators. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. Eur Heart J. 2015 Aug 1;36(29):1901-12. doi: 10.1093/eurheartj/ehv116. Epub 2015 May 2.
PMID: 25935875DERIVEDKholaif N, Zheng Y, Jagasia P, Himmelmann A, James SK, Steg PG, Storey RF, Westerhout CM, Armstrong PW. Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex. Am J Med. 2015 Aug;128(8):914.e11-9. doi: 10.1016/j.amjmed.2015.03.005. Epub 2015 Mar 26.
PMID: 25818495DERIVEDCowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-Ray L, Nikolic E, Janzon M, Levin LA, Cannon CP, Harrington RA, Mark DB. Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study. J Am Coll Cardiol. 2015 Feb 10;65(5):465-76. doi: 10.1016/j.jacc.2014.11.034.
PMID: 25660925DERIVEDJanzon M, James S, Cannon CP, Storey RF, Mellstrom C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart. 2015 Jan;101(2):119-25. doi: 10.1136/heartjnl-2014-305864. Epub 2014 Sep 16.
PMID: 25227704DERIVEDVarenhorst C, Alstrom U, Braun OO, Storey RF, Mahaffey KW, Bertilsson M, Cannon CP, Scirica BM, Himmelmann A, James SK, Wallentin L, Held C. Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes. Heart. 2014 Nov;100(22):1762-9. doi: 10.1136/heartjnl-2014-305619. Epub 2014 Jun 23.
PMID: 24957530DERIVEDKotsia A, Brilakis ES, Held C, Cannon C, Steg GP, Meier B, Cools F, Claeys MJ, Cornel JH, Aylward P, Lewis BS, Weaver D, Brandrup-Wognsen G, Stevens SR, Himmelmann A, Wallentin L, James SK. Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2014 Jul;168(1):68-75.e2. doi: 10.1016/j.ahj.2014.04.001. Epub 2014 Apr 13.
PMID: 24952862DERIVEDPatel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, Husted S, Mahaffey KW, Steg PG, Storey RF, Wallentin L, James SK. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. Eur J Prev Cardiol. 2015 Jun;22(6):734-42. doi: 10.1177/2047487314533215. Epub 2014 May 15.
PMID: 24830710DERIVEDHusted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATO study group. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2014 Jun 14;35(23):1541-50. doi: 10.1093/eurheartj/ehu075. Epub 2014 Mar 28.
PMID: 24682844DERIVEDMahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2014 Apr 22;63(15):1493-9. doi: 10.1016/j.jacc.2014.01.038. Epub 2014 Feb 19.
PMID: 24561148DERIVEDWallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2014 Jan 21;129(3):293-303. doi: 10.1161/CIRCULATIONAHA.113.004420. Epub 2013 Oct 29.
PMID: 24170388DERIVEDBrilakis ES, Held C, Meier B, Cools F, Claeys MJ, Cornel JH, Aylward P, Lewis BS, Weaver D, Brandrup-Wognsen G, Stevens SR, Himmelmann A, Wallentin L, James SK. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Am Heart J. 2013 Sep;166(3):474-80. doi: 10.1016/j.ahj.2013.06.019. Epub 2013 Jul 26.
PMID: 24016496DERIVEDSteg PG, Harrington RA, Emanuelsson H, Katus HA, Mahaffey KW, Meier B, Storey RF, Wojdyla DM, Lewis BS, Maurer G, Wallentin L, James SK; PLATO Study Group. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation. 2013 Sep 3;128(10):1055-65. doi: 10.1161/CIRCULATIONAHA.113.002589. Epub 2013 Jul 30.
PMID: 23900047DERIVEDKunadian V, James SK, Wojdyla DM, Zorkun C, Wu J, Storey RF, Steg PG, Katus H, Emanuelsson H, Horrow J, Maya J, Wallentin L, Harrington RA, Gibson CM. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). JACC Cardiovasc Interv. 2013 Jul;6(7):671-83. doi: 10.1016/j.jcin.2013.03.014.
PMID: 23866179DERIVEDJames SK, Storey RF, Pieper KS, Cannon CP, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO Study Group. Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". Stroke. 2013 Aug;44(8):e95-6. doi: 10.1161/STROKEAHA.113.002069. Epub 2013 Jun 25. No abstract available.
PMID: 23800556DERIVEDJames SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, Wallentin L, Harrington RA; PLATO study group. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013 May;44(5):1477-9. doi: 10.1161/STROKEAHA.111.000514. Epub 2013 Apr 9. No abstract available.
PMID: 23572474DERIVEDKohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation. 2013 Feb 12;127(6):673-80. doi: 10.1161/CIRCULATIONAHA.112.124248. Epub 2012 Dec 31.
PMID: 23277305DERIVEDAkerblom A, Wallentin L, Siegbahn A, Becker RC, Budaj A, Horrow J, Husted S, Katus H, Claeys MJ, Storey RF, Asenblad N, James SK. Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study. Am Heart J. 2012 Nov;164(5):728-34. doi: 10.1016/j.ahj.2012.08.017. Epub 2012 Oct 17.
PMID: 23137503DERIVEDVarenhorst C, Alstrom U, Scirica BM, Hogue CW, Asenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2012 Oct 23;60(17):1623-30. doi: 10.1016/j.jacc.2012.07.021. Epub 2012 Sep 26.
PMID: 23021325DERIVEDHusted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L; PLATO study group. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):680-8. doi: 10.1161/CIRCOUTCOMES.111.964395.
PMID: 22991347DERIVEDCornel JH, Becker RC, Goodman SG, Husted S, Katus H, Santoso A, Steg G, Storey RF, Vintila M, Sun JL, Horrow J, Wallentin L, Harrington R, James S. Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2012 Sep;164(3):334-342.e1. doi: 10.1016/j.ahj.2012.06.005. Epub 2012 Jul 26.
PMID: 22980299DERIVEDNikolic E, Janzon M, Hauch O, Wallentin L, Henriksson M; PLATO Health Economic Substudy Group. Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J. 2013 Jan;34(3):220-8. doi: 10.1093/eurheartj/ehs149. Epub 2012 Jun 19.
PMID: 22719022DERIVEDJames SK, Storey RF, Khurmi NS, Husted S, Keltai M, Mahaffey KW, Maya J, Morais J, Lopes RD, Nicolau JC, Pais P, Raev D, Lopez-Sendon JL, Stevens SR, Becker RC; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. Circulation. 2012 Jun 12;125(23):2914-21. doi: 10.1161/CIRCULATIONAHA.111.082727. Epub 2012 May 9.
PMID: 22572911DERIVEDSiha H, Das D, Fu Y, Zheng Y, Westerhout CM, Storey RF, James S, Wallentin L, Armstrong PW. Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial. CMAJ. 2012 Jul 10;184(10):1135-42. doi: 10.1503/cmaj.111683. Epub 2012 Apr 30.
PMID: 22546885DERIVEDGoodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, Mahaffey KW, Angiolillo DJ, Husted S, Cannon CP, James SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L; Platelet Inhibition and Patient Outcomes Trial Investigators. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012 Feb 28;125(8):978-86. doi: 10.1161/CIRCULATIONAHA.111.032912. Epub 2012 Jan 18.
PMID: 22261200DERIVEDArmstrong PW, Siha H, Fu Y, Westerhout CM, Steg PG, James SK, Storey RF, Horrow J, Katus H, Clemmensen P, Harrington RA, Wallentin L. ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy. Circulation. 2012 Jan 24;125(3):514-21. doi: 10.1161/CIRCULATIONAHA.111.047530. Epub 2011 Dec 16.
PMID: 22179530DERIVEDBecker RC, Bassand JP, Budaj A, Wojdyla DM, James SK, Cornel JH, French J, Held C, Horrow J, Husted S, Lopez-Sendon J, Lassila R, Mahaffey KW, Storey RF, Harrington RA, Wallentin L. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2011 Dec;32(23):2933-44. doi: 10.1093/eurheartj/ehr422. Epub 2011 Nov 16.
PMID: 22090660DERIVEDMahaffey KW, Wojdyla DM, Carroll K, Becker RC, Storey RF, Angiolillo DJ, Held C, Cannon CP, James S, Pieper KS, Horrow J, Harrington RA, Wallentin L; PLATO Investigators. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2011 Aug 2;124(5):544-54. doi: 10.1161/CIRCULATIONAHA.111.047498. Epub 2011 Jun 27.
PMID: 21709065DERIVEDJames SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, Katus H, Morais J, Steg PG, Storey RF, Stevens S, Wallentin L, Harrington RA; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ. 2011 Jun 17;342:d3527. doi: 10.1136/bmj.d3527.
PMID: 21685437DERIVEDScirica BM, Cannon CP, Emanuelsson H, Michelson EL, Harrington RA, Husted S, James S, Katus H, Pais P, Raev D, Spinar J, Steg PG, Storey RF, Wallentin L; PLATO Investigators. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J Am Coll Cardiol. 2011 May 10;57(19):1908-16. doi: 10.1016/j.jacc.2010.11.056.
PMID: 21545948DERIVEDSteg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation. 2010 Nov 23;122(21):2131-41. doi: 10.1161/CIRCULATIONAHA.109.927582. Epub 2010 Nov 8.
PMID: 21060072DERIVEDJames S, Budaj A, Aylward P, Buck KK, Cannon CP, Cornel JH, Harrington RA, Horrow J, Katus H, Keltai M, Lewis BS, Parikh K, Storey RF, Szummer K, Wojdyla D, Wallentin L. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2010 Sep 14;122(11):1056-67. doi: 10.1161/CIRCULATIONAHA.109.933796. Epub 2010 Aug 30.
PMID: 20805430DERIVEDCannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATelet inhibition and patient Outcomes Investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet. 2010 Jan 23;375(9711):283-93. doi: 10.1016/S0140-6736(09)62191-7. Epub 2010 Jan 13.
PMID: 20079528DERIVEDWallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators; Freij A, Thorsen M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.
PMID: 19717846DERIVEDMolecule of the month. Ticagrelor. Drug News Perspect. 2007 May;20(4):264. No abstract available.
PMID: 17637939DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gerard Lynch
- Organization
- AstraZeneca
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Harrington, MD
Duke Clinical Research Institute
- PRINCIPAL INVESTIGATOR
Lars Wallentin, MD
Uppsala Clinical Research Centre
- STUDY DIRECTOR
Jonathan C. Fox, MD
AstraZeneca
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2006
First Posted
October 25, 2006
Study Start
October 1, 2006
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
March 13, 2012
Results First Posted
March 13, 2012
Record last verified: 2012-02